Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

Coronavirus: Bharat Biotech’s Covaxin is 77.8 per cent effective in protecting against COVID-19 – according to results of Phase III trial data approved by the DCGI’s Subject Expert Committee -…

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!